What happened
Goldman Sachs crowned Every Cure, a Frankfurt analyst team, winner of its 11th Analyst Impact Fund, awarding it $250,000 of the $650,000 given to finalists for AI-powered drug research.
Why it matters
The prize lets the four-person team expand and push more drug-disease combinations into clinical trials, giving junior analysts direct say over the bank's charitable money.
WHO IT HITSJunior Goldman Sachs analysts gain a direct channel to shape the bank's philanthropy and build presentation and leadership skills, while the winning nonprofits receive grants to scale their work.
Summaries like this, every morning.
The Analyst Impact Fund began when two Goldman partners brainstormed ways to connect junior talent with the company's culture of service, according to Asahi Pompey, global head of corporate engagement and president of the Goldman Sachs Foundation. What started as a small competition with a few teams presenting to the CEO has grown into one of the bank's most popular events. Pompey noted that only 1,000 analysts participated across the program's first three years, while in 2026, 1,063 workers across 45 Goldman offices competed in a single year.
The competition also serves as a leadership pipeline. Pompey said one in six partners mentored a team, and past participants coached newer associates. CEO David Solomon said in a press release that the program gives analysts the chance to engage with complex global challenges while developing leadership, resilience, and adaptability. The bank says the benefits extend beyond the grants themselves, helping analysts hone presentation skills and connect face-to-face with senior executives.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Warp Sciences, an AI-and-robot chemistry CRO led by ex-OpenAI product chief Kevin Weil, launched on the 22nd w…
Merck announced a collaboration with NVIDIA, Microsoft and Dawn Health to build an AI digital companion offeri…
Samsung Seoul Hospital rose to 4th in Newsweek's World's Best Smart Hospitals 2027, up from 15th a year earlie…
Microsoft's Diagnostic Orchestrator, powered by OpenAI's GPT-5, scored about 83 percent diagnostic accuracy on…
In a Science study using complex New England Journal of Medicine cases, Microsoft's MAI-DxO was correct 83% of…
Amazon Quick is now HIPAA-eligible across its web, desktop, and mobile clients, letting organizations process…
